New antitumor antibiotics, ditrisarubicins A, B and C.
D000818:Animals; D018943:Anthracyclines; D000900:Anti-Bacterial Agents / Q000302:isolation & purification*; D000903:Antibiotics, Antineoplastic; D001419:Bacteria / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D006601:Hexoses / Q000032:analysis; D007939:Leukemia L1210 / Q000188:drug therapy / Q000503:physiopathology; D013058:Mass Spectrometry; D051379:Mice; D008826:Microbial Sensitivity Tests; D009279:Naphthacenes / Q000302:isolation & purification / Q000633:toxicity; D009904:Optical Rotation; D013055:Spectrophotometry, Infrared; D013302:Streptomyces / Q000254:growth & development; D013329:Structure-Activity Relationship; D014158:Transcription, Genetic / Q000187:drug effects
D018943:Anthracyclines; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D006601:Hexoses; D009279:Naphthacenes; C039540:ditrisarubicin C; C039539:ditrisarubicin B; C039538:ditrisarubicin A